Immune responses against different variants of SARS-CoV-2 including Omicron following 6 months of administration of heterologous prime-boost COVID-19 vaccine.

Gajanan N SapkalRajni KantGaurav DwivediRima R SahayPragya Dhruv YadavGururaj R DeshpandeRajeev SinghDimpal A NyayanitDeepak Y PatilAnita M Shete-AichKamran ZamanAnil K ChaudhariNivedita GuptaSamiran PandaPriya AbrahamBalram Bhargava

Published in: Journal of travel medicine (2022)

Keyphrases

sars cov
immune response
respiratory syndrome coronavirus
copy number
toll like receptor
coronavirus disease
saccharomyces cerevisiae
gene expression
dna methylation